Add to Favorites Newsroom RSS Share
Aurora, CO USA

Our News on Newswise

Microbiome Predicts Blood Infections in Pediatric Cancer Patients


Patients who developed bloodstream infections had significantly reduced microbiome diversity than patients who remained free of infection.
22-Jan-2018 11:05 AM EST Add to Favorites

Treatment-Related Mortality of Surgery vs. Targeted Radiation in Early Lung Cancer Patients


Among patients older than 80 years, 3.9 percent receiving surgery passed away within the 30-day post-treatment window, compared with 0.9 percent of patients receiving focused radiation.
19-Jan-2018 8:05 AM EST Add to Favorites

Radiosurgery vs. Whole-Brain Radiation in Lung Cancer Patients with Multiple Brain Metastases


University of Colorado Cancer Center study shows that radiosurgery may effectively treat brain metastases associated with certain types of lung cancer, even when the number of metastases exceeds established norms.
19-Dec-2017 11:05 AM EST Add to Favorites

Even Smokers May Benefit From Targeted Lung Cancer Treatments

When a targetable genetic alteration is present, matching the alteration with the appropriate targeted therapy is associated with a survival benefit of 1.5 years, regardless of smoking history.
13-Dec-2017 11:05 AM EST Add to Favorites

Some Chemicals in Smoke May Be Even More Dangerous Than Previously Thought

Though most “low molecular weight polycyclic aromatic hydrocarbons” (LMW PAHs) have not been shown to cause cancer alone, the study shows that in common combinations, these chemicals can help to spark the disease.
30-Nov-2017 4:10 PM EST Add to Favorites

Study Finds a New Way to Shut Down Cancer Cells’ Ability to Consume Glucose

Many cancers depend on glucose consumption for energy, but good pharmacological targets to stop cancers’ ability to uptake and metabolize glucose are missing. CU Cancer Center study finally identifies a way to restrict the ability of cancer to use...
7-Nov-2017 11:05 AM EST Add to Favorites

Important New Insights Into RECIST Criteria Measuring Cancer’s Response to Treatment


CU Cancer Center study examines current RECIST guidelines in an effort to bring them up to speed with new complexities presented by the latest targeted therapies.
6-Nov-2017 4:35 PM EST Add to Favorites

In the Lab and in the Clinic, Alisertib with TAK-228 Excels Against Solid Tumors, Including Triple-Negative Breast Cancer


Two University of Colorado Cancer Center studies presented this weekend at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting show that using the drug alisertib along with the drug TAK-228 is more effective against triple-negative...
1-Nov-2017 11:05 AM EDT Add to Favorites

Our Experts on Newswise

Will One Bad Sunburn Give You Skin Cancer?


27-Jul-2015 11:05 AM EDT

Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing


An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.

Chat now!